臺灣血液透析實作指引 (TW HD IG)
0.0.2 - ci-build
臺灣血液透析實作指引 (TW HD IG) - Local Development build (v0.0.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://fhir.muen.tw/ig/hd/ValueSet/epo-type-atc-vs | Version: 0.0.2 | |||
| Draft as of 2026-06-11 | Computable Name: EpoTypeAtcVS | |||
紅血球生成素 (EPO/ESA) 之 WHO ATC 代碼。
References
http://www.whocc.no/atc version Not Stated (use latest from terminology server)| Code | Display |
| B03XA01 | 紅血球生成素 epoetin alfa/beta (erythropoietin) |
| B03XA02 | 達貝泊汀 alfa,Nesp (darbepoetin alfa) |
| B03XA03 | 甲氧基聚乙二醇 epoetin beta,Mircera (methoxy polyethylene glycol-epoetin beta) |
| B03XA | 其他抗貧血製劑 (Other antianemic preparations) |
Expansion from tx.fhir.org based on codesystem WHO ATC version 2025
This value set contains 4 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |